Background: Immune checkpoint inhibitors have revolutionized the treatment of urothelial bladder cancer (UBC), yet response remains limited to a subset of patients. The SWItch/sucrose non-fermentable ...

Intestinal injury remains difficult to treat due to persistent inflammation and limited regenerative capacity. Here, we show that deletion of double PHD fingers 2 (DPF2) promotes intestinal repair by ...

aKey Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Bone and Soft Tissue Tumour, Peking University Cancer Hospital & Institute, Beijing, China ...

Please provide your email address to receive an email when new articles are posted on . V Foundation for Cancer Research has named Diana Hargreaves, PhD, a 2025 All-Star Translational Award Program ...

Find contact details for all general enquiries and outreach programs. ANU researchers and global partners are launching a clinical trial to improve treatment for Kaposi sarcoma, one of the most common ...

Salk Institute Professor Diana Hargreaves was named a 2025 All-Star Translational Award Program grantee by the V Foundation for Cancer Research. The award comes as a recognition of Hargreaves' ...

LA JOLLA (July 24, 2025)—Salk Institute Professor Diana Hargreaves was named a 2025 All-Star Translational Award Program grantee by the V Foundation for Cancer Research. The award comes as a ...

Muscle development and metabolic homeostasis are critical aspects of human health. As a key component of the SWI/SNF chromatin remodeling complex, the BAF60 subunit plays a widespread and crucial role ...